← Back to headlines
BTIG Adjusts Humacyte (HUMA) Price Target While Maintaining Bullish Outlook
BTIG has lowered its price target for Humacyte (HUMA) but continues to hold a bullish view on the company's long-term opportunities.
29 Mar, 20:44 — 29 Mar, 20:44
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Boracay Water's Nabaoy Watershed Rehabilitation Validated by DENR
just now
UP President Addresses Commercialization Concerns on Diliman Campus
just now
Scrutiny Intensifies Over Philippine VP Sara Duterte's SALNs and Business Interests
just now